The Single-use Bioreactors Market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% from 2023 to 2030. Single-use bioreactors, also called disposable bioreactors, are made of disposable bags instead of a culture vessel. These bioreactors eliminate the need for expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) systems and offer flexibility and a low risk of contamination, contributing to their adoption by pharma & biotech companies. These companies are focusing on organic & inorganic strategies like expanding manufacturing capacity or acquisitions to increase their bioproduction, increasing the adoption of biopharma equipment, including bioreactors.
For instance, in December 2022, Thermo Fisher Scientific Inc. (U.S.) expanded its presence in Hangzhou, China, to support customers' manufacturing needs, enabling them to serve more patients worldwide. This site offers integrated clinical and commercial drug substance and drug product capabilities, including process development, cell line development, biologics drug substance manufacturing and sterile fill-finish. This includes the use of packaging and labeling capabilities. Advanced technologies in the facility include Thermo Fisher 2,000-liter HyPerforma Single-Use Bioreactors and associated Single-Use equipment and, in the future, bioreactor capacity up to 5,000 liters through Thermo Scientific DynaDrive technology.
In March 2021, Pall Corporation (U.S.), a subsidiary of Danaher Corporation (U.S.), acquired Pall-Austar Lifesciences Limited (Hong Kong) (a joint Venture between Pall and Austar Group). This acquisition is intended to expand the single-use technology manufacturing capabilities of the company in China for products supporting the scale-up of COVID-19 vaccines.
The rapid adoption of disposable technology in the pharmaceutical and biotechnology industry, growing demand for biopharmaceuticals, and capacity expansion of biopharmaceutical plants are some of the major factors driving the growth of the single-use bioreactors market.
Recently, the manufacturing of various biopharma products, such as vaccines and biosimilars, has increased due to the price advantage compared to biologics, the COVID-19 pandemic, and biosimilar substitution laws. Biopharmaceutical manufacturers and CDMOs are increasing their capacity through expansions, which will generate additional demand for biopharmaceutical manufacturing equipment and consumables, propelling the growth of this market.
For instance, in June 2022, Merck KGaA (Germany) expanded its Life Science business sector by establishing a facility in Wisconsin, U.S. This USD 62 million (EUR 59 million) site is expected to increase high-potent active pharmaceutical ingredients (HPAPI) production capacity. Furthermore, in May 2022, Sartorius AG (Germany) established a new manufacturing site in Tunisia to increase its fluid management technology production, thereby meeting the high demand from the biopharmaceutical industry.
Click here to: Get a Free Sample Copy of this report
The Rising Adoption of Personalized Medicines is an Opportunity for the Players in this Market
Personalized medicine is an emerging practice that uses an individual's genetic profile to guide disease prevention, diagnosis, and treatment decisions. These medicines are now considered the mainstream clinical approach, thereby changing disease identification, classification, and treatment method.
According to a report published by the Personalized Medicine Coalition, personalized medicines are increasing rapidly. The share of personalized medicine increased steadily in the total drugs approved in the U.S. by FDA from 28% in 2015 to 35% in 2021. In 2021, the FDA’s Center for Drug Evaluation and Research (CDER) approved 48 new molecular entities (NMEs) (drugs, agents, or therapeutic biologics). Out of these 48 drugs, 17 were classified as personalized medicines. Globally, the number of personalized medicines was 132 in 2016, which increased to 286 in 2020. The increasing number of FDA approvals and the availability of new personalized medicines are expected to create demand for their upstream processing equipment, such as bioreactors.
Based on Product, the Media Bags Segment is Projected to Register the Highest CAGR
The growth of this segment is driven by its benefits, such as high flexibility, low levels of extractable and leachable, and product stability during storage compared to culture vessels.
Based on type, the Wave-induced Bioreactors Segment is Projected to Register the Highest CAGR
In contrast to conventional stirred tank bioreactors, wave-induced bioreactor systems do not rely on oxygen bubbles for culture aeration or agitators for mixing. Instead, these bioreactors' large surface-to-volume ratio and rocking motion generate surface aeration to meet the oxygen demands of mammalian cell cultures, often exceeding those delivered by stirred tanks. Rocking-motion bioreactor systems have also been shown to improve fluid turnover and minimize shear forces compared to stirred tanks. Such flow conditions reportedly produce better cell suspension and reduce the risk of cell damage, enabling rocking-motion bioreactors to reach higher maximum cell densities than traditional spinner flasks. All these advantages of wave-induced bioreactors contribute to the growth of this segment.
In 2023, the Mammalian Cells Segment is Expected to Account for the Largest Share
Based on cell type, in 2023, the mammalian cells segment is expected to account for the largest share of the market. Mammalian cells are mostly used for mAbs production and can produce large amounts of mAbs with a consistent quality and adapt well to culture in large-scale suspension bioreactors. These cells can perform the required protein folding, assembly and post-translational modifications such as glycosylation and provide greater commercial success for protein & genomic research, thus driving the adoption of single-use bioreactors.
In 2023, the Commercial Bio-Production Segment is Expected to Account for the Largest Share
Based on application, in 2023, the commercial bio-production segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing support from regulatory agencies & initiatives by biopharma companies. For instance, in October 2021, the U.S. Food and Drug Administration, the National Institutes of Health (NIH), 10 pharmaceutical companies, and five non-profit organizations partnered to accelerate the development of gene therapies for the 30 million Americans suffering from rare diseases. In January 2021, Cognate BioServices, Inc. (U.S.), a cell and gene therapy CDMO, announced plans to expand its cell and gene therapy manufacturing facility, warehouse capabilities, and laboratory space at its U.S. and European sites.
In 2023, the Pharmaceutical & Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Market
The large market share of this segment is attributed to the rise in R&D activities, high adoption of bioreactors in pharmaceutical laboratories, and concerns over flexibility, sterility, cost efficiency, and enhanced productivity.
Europe: Largest Regional Market
The growth of this market is driven by the increasing sales of drugs, support from government and regulatory authorities to promote the use of biopharmaceuticals for various health indications, and various companies expanding their manufacturing capacities as well as their operations.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants in the last 3 to 4 years. The key players profiled in the single-use bioreactors market report are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).
Scope of the Report:
Single-use Bioreactors Market, by Product
Single-use Bioreactors Market, by Type
Single-use Bioreactors Market, by Cell Type
Single-use Bioreactors Market, by Application
Single-use Bioreactors Market, by End User
Single-use Bioreactors Market, by Geography
Key questions answered in the report:
This study offers a detailed assessment of the single-use bioreactors market, including the market size & forecast for various segmentations, including product, type, cell type, application, and end user. The single-use bioreactors market studied in this report also involves the value analysis of various segments and sub-segments of single-use bioreactors at regional and country levels.
The global single-use bioreactors market is projected to reach $10.3 billion by 2030, at a CAGR of 15.3% during the forecast period.
Based on product, in 2023, the single-use bioreactor systems segment is expected to account for the largest share of the single-use bioreactors market.
Based on type, the wave-induced bioreactors segment is projected to register the highest CAGR over the forecast period. The advantages offered by these bioreactors over stirred-tank and increasing cell-based research supporting their adoption are the key factors supporting the growth of this market.
The growth of this market is driven by the growing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, rising pharmaceutical R&D expenditures, the growing adoption of biosimilars, and the increasing prevalence of chronic diseases. Moreover, emerging economies and the increasing adoption of personalized medicines offer significant opportunities for the players operating in this market.
The key players profiled in the global single-use bioreactors market report are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).
Emerging economies in Asia-Pacific are projected to offer significant growth opportunities to the market players due to the increasing disposable income and rising foreign direct investments (FDI) for pharmaceuticals and biopharmaceutical companies, driving the market growth in this market.
This report provides pre & post COVID-19 market estimates.
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Factor Analysis
4.3. Market Trends
4.3.1. Use of Hybrid Systems
4.3.2. Rising Focus on Continuous Bioprocessing
4.3.3. Shift Toward Bioprocessing 4.0
4.3.4. Integration of AI in Bioprocessing
4.4. Parent Market Analysis: Biopharmaceutical Processing Equipment and Consumables Market
5. Single-use Bioreactors Market Assessment—by Product
5.1. Overview
5.2. Single-use Bioreactor Systems
5.2.1. Upto 10 Liters Single-use Bioreactor Systems
5.2.2. 11–500 Liters Single-use Bioreactor Systems
5.2.3. 501–1000 Liters Single-use Bioreactor Systems
5.2.4. Above 1001 Liters Single-use Bioreactor Systems
5.3. Media Bags
5.3.1. 2D Media Bags
5.3.2. 3D Media Bags
5.3.3. Linear Media Bags
5.4. Filtration Assemblies
5.5. Other Products
6. Single-use Bioreactors Market Assessment—by Type
6.1. Overview
6.2. Stirred-tank Bioreactors
6.3. Wave-induced Bioreactors
6.4. Other Single-use Bioreactors
7. Single-use Bioreactors Market Assessment—by Cell Type
7.1. Overview
7.2. Mammalian Cells
7.3. Bacterial Cells
7.4. Yeast Cells
7.5. Other Cells
8. Single-use Bioreactors Market Assessment—by Application
8.1. Overview
8.2. Commercial Bioproduction
8.2.1. Monoclonal Antibody Production
8.2.2. Therapeutic Protein Production
8.2.3. Vaccine Production
8.2.4. Cell And Gene Therapy
8.3. Research Bioproduction
9. Single-use Bioreactors Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical And Biopharmaceutical Companies
9.3. Contract Development and Manufacturing Organizations & Contract Research Organizations
9.4. Academic & Research Institutes
10. Single-use Bioreactors Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Switzerland
10.3.6. Spain
10.3.7. Ireland
10.3.8. Denmark
10.3.9. Belgium
10.3.10. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.6. Middle East & Africa
11. Competition Analysis
11.1. Introduction
11.2. Key Growth Strategies
11.3. Vendor Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis of Top 5 Companies)
12.1. Thermo Fisher Scientific Inc.
12.2. Danaher Corporation
12.3. Merck KGaA
12.4. Eppendorf AG
12.5. Sartorius AG
12.6. Solaris Biotechnology Srl (A Subsidiary Of Donaldson Company, Inc.)
12.7. Cellexus International Ltd.
12.8. CESCO Bioengineering Co., Ltd.
12.9. Distek, Inc.
12.10. Infors AG
12.11. PBS Biotech, Inc.
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Cancer Incidence, by Type, 2020 Vs. 2030 (In Thousands)
Table 2 GLOBAL Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 3 Global Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 4 Global Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Companies Offering Upto 10 Liters Single-use Bioreactor Systems
Table 6 Global Upto 10 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Vendors offering 11–500 Liters Single-use Bioreactor Systems
Table 8 Global 11–500 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Vendors offering 501–1000 Liters Single-use Bioreactor Systems
Table 10 Global 501–1000 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Vendors offering Above 1001 Liters Single-use Bioreactor Systems
Table 12 Global Above 1001 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Single-use Bioreactor Media Bags Market, by Type, 2021–2030(USD Million)
Table 14 Global Single-use Bioreactor Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Single-use 2D Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Single-use 3D Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Single-use Linear Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Single-use Bioreactor Filtration Assemblies Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Other Single-use Bioreactor Products Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 21 Global Stirred-Tank Single-use Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Wave-Induced Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Other Single-use Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 25 Global Single-use Bioreactors Market for Mammalian Cells, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Single-use Bioreactors Market for Bacterial Cells, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Single-use Bioreactor Market for Yeast Cells, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Single-use Bioreactor Market for Other Cells, by Country/Region, 2021–2030 (USD Million)
Table 29 GLOBAL Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 30 Global Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 31 Global Single-use Bioreactors Market for Commercial Bioproduction, by Country /Region, 2021–2030 (USD Million)
Table 32 Global Single-use Bioreactors Market for Monoclonal Antibody Production, by Country/Region, 2021–2030 (USD Million)
Table 33 Global Single-use Bioreactors Market for Therapeutic Protein Production, by Country/Region, 2021–2030 (USD Million)
Table 34 Global Single-use Bioreactors Market for Vaccine Production, by Country/Region, 2021–2030 (USD Million)
Table 35 Global Single-use Bioreactors Market for Cell and Gene Therapy, by Country/Region, 2021–2030 (USD Million)
Table 36 Number of Registered Studies by Location (As of February 17, 2023)
Table 37 Global Single-use Bioreactors Market for Research Bioproduction, by Country/Region, 2021–2030 (USD Million)
Table 38 GLOBAL Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 39 Recent Developments by Pharma & Biopharma Companies
Table 40 Global Single-use Bioreactors Market for Pharmaceutical and Biopharmaceutical Companies, by Country/Region, 2021–2030 (USD Million)
Table 41 Recent Developments by CDMO & CRO
Table 42 Global Single-use Bioreactors Market for CDMO & CRO, by Country/Region, 2021–2030 (USD Million)
Table 43 Recent Developments by Academic & Research Institutes
Table 44 Global Single-use Bioreactor Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 45 Global Single-use Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 46 North America: Single-use Bioreactors Market, by Country, 2021–2030 (USD Million)
Table 47 North America: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 48 North America: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 49 North America: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 50 North America: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 51 North America: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 52 North America: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 53 North America: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 54 North America: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 55 U.S.: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 56 U.S.: Single-use Bioreactor Systems Market, by Type, 2021–2030(USD Million)
Table 57 U.S.: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 58 U.S: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 59 U.S.: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 60 U.S.: Single-use Bioreactors Market, by Application, 2021–2030(USD Million)
Table 61 U.S.: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 62 U.S.: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 63 Canada: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 64 Canada: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 65 Canada: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 66 Canada: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 67 Canada: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 68 Canada: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 69 Canada: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 70 Canada: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 71 Europe: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 72 Europe: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 73 Europe: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 74 Europe: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 75 Europe: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 76 Europe: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 77 Europe: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 78 Europe: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 79 Germany: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 80 Germany: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 81 Germany: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 82 Germany: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 83 Germany: Single-use Bioreactors Market, by Cell TYPE, 2021–2030 (USD Million)
Table 84 Germany: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 85 Germany: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 86 Germany: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 87 France: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 88 France: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 89 France: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 90 France: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 91 France: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 92 France: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 93 France: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 94 France: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 95 U.K.: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 96 U.K.: Single-use Bioreactor Systems Market, by Type, 2021–2030(USD Million)
Table 97 U.K.: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 98 U.K.: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 99 U.K.: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 100 U.K.: Single-use Bioreactors Market, by Application, 2021–2030(USD Million)
Table 101 U.K.: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 102 U.K.: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 103 Italy: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 104 Italy: Single-use Bioreactor Systems Market, by Type, 2021–2030(USD Million)
Table 105 Italy: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 106 Italy: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 107 Italy: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 108 Italy: Single-use Bioreactors Market, by Application, 2021–2030(USD Million)
Table 109 Italy: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 110 Italy: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 111 Switzerland: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 112 Switzerland: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 113 Switzerland: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 114 Switzerland: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 115 Switzerland: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 116 Switzerland: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 117 Switzerland: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 118 Switzerland: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 119 Spain: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 120 Spain: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 121 Spain: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 122 Spain: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 123 Spain: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 124 Spain: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 125 Spain: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 126 Spain: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 127 Ireland: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 128 Ireland: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 129 Ireland: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 130 Ireland: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 131 Ireland: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 132 Ireland: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 133 Ireland: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 134 Ireland: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 135 Denmark: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 136 Denmark: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 137 Denmark: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 138 Denmark: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 139 Denmark: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 140 Denmark: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 141 Denmark: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 142 Denmark: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 143 Belgium: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 144 Belgium: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 145 Belgium: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 146 Belgium: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 147 Belgium: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 148 Belgium: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 149 Belgium: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 150 Belgium: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 151 RoE: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 152 RoE: Single-use Bioreactor Systems Market, by Type, 2021–2030(USD Million)
Table 153 RoE: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 154 RoE: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 155 RoE: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 156 RoE: Single-use Bioreactors Market, by Application, 2021–2030(USD Million)
Table 157 RoE: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 158 RoE: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 159 Asia-Pacific: Single-use Bioreactors Market, by Country, 2021–2030(USD Million)
Table 160 Asia-Pacific: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 161 Asia-Pacific: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 162 Asia-Pacific: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 163 Asia-Pacific: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 164 Asia-Pacific: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 165 Asia-Pacific: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 166 Asia-Pacific: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 167 Asia-Pacific: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 168 China: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 169 China: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 170 China: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 171 China: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 172 China: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 173 China: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 174 China: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 175 China: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 176 India: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 177 India: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 178 India: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 179 India: Single-use Bioreactors MARKET, by Type, 2021–2030 (USD Million)
Table 180 India: Single-use Bioreactors Market, by Cell TYPE, 2021–2030 (USD Million)
Table 181 India: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 182 India: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 183 India: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 184 Japan: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 185 Japan: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 186 Japan: Single-use Bioreactor Media Bags Market, by Type, 2021–2030(USD Million)
Table 187 Japan: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 188 Japan: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 189 Japan: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 190 Japan: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 191 Japan: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 192 South Korea: Single-use Bioreactors Market, by Product, 2021–2030(USD Million)
Table 193 South Korea: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 194 South Korea: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 195 South Korea: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 196 South Korea: Single-use Bioreactors Market, by Cell Type, 2021–2030(USD Million)
Table 197 South Korea: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 198 South Korea: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 199 South Korea: Single-use Bioreactors Market, by End User, 2021–2030(USD Million)
Table 200 RoAPAC: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 201 RoAPAC: Single-use Bioreactor Systems Market, by Type, 2021–2030(USD Million)
Table 202 RoAPAC: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 203 RoAPAC: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 204 RoAPAC: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 205 RoAPAC: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 206 RoAPAC: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 207 RoAPAC: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 208 Latin America: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 209 Latin America: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 210 Latin America: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 211 Latin America: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 212 Latin America: Single-use Bioreactors Market, by Cell TYPE, 2021–2030 (USD Million)
Table 213 Latin America: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 214 Latin America: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 215 Latin America: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 216 Middle East & Africa: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 217 Middle East & Africa: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 218 Middle East & Africa: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 219 Middle East & Africa: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 220 Middle East & Africa: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 221 Middle East & Africa: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 222 Middle East & Africa: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 223 Middle East & Africa: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 224 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Single-use Bioreactors Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Single-use Bioreactors Market, by Type, 2023 Vs.2030 (USD Million)
Figure 9 Global Single-use Bioreactors Market, by Cell Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Single-use Bioreactors Market, by Application, 2023 Vs.2030 (USD Million)
Figure 11 Global Single-use Bioreactors Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global Single-use Bioreactors Market, by Geography
Figure 13 Impact Analysis: Single-use Bioreactors Market
Figure 14 Global Prescription Drug Sales, 2014–2028 (USD Billion)
Figure 15 Global Pharmaceutical R&D Spend, 2014–2028 (USD Billion)
Figure 16 Number of Biosimilars Approved in the U.S. and EU, 2014–2022
Figure 17 Global Geriatric Population (Aged 60 Years & Above), 2019–2050
Figure 18 Global Biopharmaceutical Processing Equipment and Consumables Market Size, 2022 Vs. 2029 (USD Million)
Figure 19 Global Single-use Bioreactors Market, by Product, 2023–2030 (USD Million)
Figure 20 Global Single-use Bioreactors Market, by Type, 2023–2030 (USD Million)
Figure 21 Global Single-use Bioreactors Market, by Cell Type, 2023–2030 (USD Million)
Figure 22 Global Single-use Bioreactors Market, by Application, 2023–2030 (USD Million)
Figure 23 Vaccine Projects in the Pipeline: 2020
Figure 24 Vaccine Doses: 2019 and 2021 (In Billion)
Figure 25 Number of Proteins Approved by FDA: 2017-2021
Figure 26 Global Single-use Bioreactors Market, by End User, 2023–2030 (USD Million)
Figure 27 Global Pharmaceutical R&D Spend (USD Billion)
Figure 28 Global Single-use Bioreactors Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 29 North America: Single-use Bioreactors Market Snapshot
Figure 30 Europe: Single-use Bioreactors Market Snapshot
Figure 31 Asia-Pacific: Single-use Bioreactors Market Snapshot
Figure 32 Key Growth Strategies Adopted by Leading Players, 2021–2023
Figure 33 Single-use Bioreactors Market: Vendor Benchmarking, by Product
Figure 34 Single-use Bioreactors Market: Vendor Benchmarking, by Region
Figure 35 Competitive Dashboard: Single-use Bioreactors Market
Figure 36 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 37 Danaher Corporation: Financial Overview (2022)
Figure 38 Merck KGaA: Financial Overview (2022)
Figure 39 Eppendorf AG: Financial Overview (2021)
Figure 40 Sartorius AG: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Sep-2019
Published Date: Oct-2018
Published Date: Dec-2022
Published Date: Jun-2019
